Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis
- PMID: 21190093
- DOI: 10.1007/s12029-010-9235-z
Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis
Abstract
Introduction: Portal vein thrombosis is frequently associated with hepatocellular carcinoma (HCC). Tumor invasion into the portal vein by direct venous extension or metastasis occurs in up to 70% of HCC patients (Cedrone et al., Liver 16:94-8, 1996). However, presentation as an isolated malignant portal vein thrombosis without any evidence of obvious hepatoma-like lesions in the liver by imaging studies is extremely uncommon. We present an unusual case of HCC presenting as a malignant portal vein thrombus, proven on biopsy of the thrombus without any evidence of primary liver lesion. This, to our knowledge, is the first case of HCC presenting as an incidental isolated malignant portal vein thrombosis. The importance of doing delayed enhancement imaging studies to rule out malignant portal vein thrombosis is emphasized.
Case report: A 60-year-old man presented with acute substernal chest pain. Physical examination revealed icterus. Examination of the abdomen did not reveal any organomegaly. Liver function test revealed a predominantly conjugated bilirubinemia. Abdominal sonogram revealed thrombosis and occlusion of the posterior right portal vein. Liver parenchyma was homogenous with no intrahepatic mass. Computed tomography (CT) of the abdomen and pelvis after administration of oral and intravenous contrast with delayed views revealed arterial enhancement of the right portal vein thrombus with delayed washout. MRI of the abdomen with gadolinium confirmed the right portal vein thrombus without focal hepatic mass. Aspiration of the right portal vein thrombus under CT guidance revealed hepatocellular carcinoma which was confirmed by immunohistochemistry. Serum alpha-fetoprotein level was very high. Patient was started on sorafenib with subsequent decrease in alpha-fetoprotein level. He was doing well till the date of this report.
Discussion: This unusual case of hepatocellular carcinoma presenting as an incidental malignant portal vein thrombosis without any primary liver lesion is extremely rare. Other reported cases of malignant portal vein thrombosis have been in patients with underlying hepatoma, cirrhosis, or with intrabiliary hepatocelluar carcinoma. In the clinical setting of portal vein thrombosis, imaging studies showing enhancement of the thrombus in the arterial phase are important in leading to the diagnosis of malignancy.
Similar articles
-
Validation of an extension of the international non-invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis.J Gastroenterol Hepatol. 2011 Apr;26(4):669-77. doi: 10.1111/j.1440-1746.2010.06564.x. J Gastroenterol Hepatol. 2011. PMID: 21054520
-
Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy.Abdom Imaging. 2006 Sep-Oct;31(5):537-44. doi: 10.1007/s00261-005-0150-x. Abdom Imaging. 2006. PMID: 16865315
-
Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.World J Gastroenterol. 2008 Feb 28;14(8):1212-7. doi: 10.3748/wjg.14.1212. World J Gastroenterol. 2008. PMID: 18300346 Free PMC article.
-
Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.World J Gastroenterol. 2015 Aug 28;21(32):9457-60. doi: 10.3748/wjg.v21.i32.9457. World J Gastroenterol. 2015. PMID: 26327753 Free PMC article. Review.
-
Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges.Oncotarget. 2017 May 16;8(20):33911-33921. doi: 10.18632/oncotarget.15411. Oncotarget. 2017. PMID: 28430610 Free PMC article. Review.
Cited by
-
Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature.J Ultrason. 2020;20(80):e55-e60. doi: 10.15557/JoU.2020.0009. Epub 2020 Mar 31. J Ultrason. 2020. PMID: 32320167 Free PMC article.
-
Implanting Iodine-125 Seed Strand Inside the Portal Vein Stent: An Improved Approach to Endovascular Brachytherapy for Treatment of Patients with Hepatocellular Carcinoma and Main Portal Vein Tumor Thrombus.J Hepatocell Carcinoma. 2023 Dec 6;10:2187-2196. doi: 10.2147/JHC.S430686. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38084210 Free PMC article.
-
Portal Vein Stenting Combined with Iodine-125 Seeds Endovascular Implantation Followed by Transcatheter Arterial Chemoembolization for Treatment of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus.Biomed Res Int. 2016;2016:3048261. doi: 10.1155/2016/3048261. Epub 2016 Nov 24. Biomed Res Int. 2016. PMID: 27999793 Free PMC article.
-
Isolated Portal Venous Hepatocellular Carcinoma.J Gastrointest Cancer. 2017 Mar;48(1):80-82. doi: 10.1007/s12029-016-9805-9. J Gastrointest Cancer. 2017. PMID: 26820465 No abstract available.
-
Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings.World J Gastroenterol. 2015 Dec 28;21(48):13524-31. doi: 10.3748/wjg.v21.i48.13524. World J Gastroenterol. 2015. PMID: 26730164 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical